Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody profiling could provide insights into disease res...

Descripción completa

Detalles Bibliográficos
Autores principales: Grace, Patricia S., Dolatshahi, Sepideh, Lu, Lenette L., Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M., Ottenhoff, Tom H. M., Lauffenburger, Douglas A., Goletti, Delia, Joosten, Simone A., Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287567/
https://www.ncbi.nlm.nih.gov/pubmed/34290702
http://dx.doi.org/10.3389/fimmu.2021.679973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287567/
https://www.ncbi.nlm.nih.gov/pubmed/34290702
http://dx.doi.org/10.3389/fimmu.2021.679973

Ejemplares similares